BiotechTube
Home/Maze Therapeutics/Courtney Phillips
CP

Courtney Phillips

General Counsel & Corporate Secretary

Maze Therapeutics

Therapeutic Areas

RenalCardiometabolicMetabolic Disorders

Maze Therapeutics Pipeline

DrugIndicationPhase
MZE829APOL1-Mediated Kidney Disease (AMKD)Phase 2
MZE782Chronic Kidney Disease (CKD) and Phenylketonuria (PKU)Phase 1/Discovery
Undisclosed GLP-1RAObesityDiscovery/Preclinical

Leadership Team at Maze Therapeutics

JC
Jason Coloma
Chief Executive Officer
HB
Harold Bernstein
President, Research and Development and Chief Medical Officer
MT
Misbah Tahir
Chief Financial Officer
AD
Atul Dandekar
Chief Strategy & Business Officer
View full Maze Therapeutics profile